Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
Active, not recruiting · NCT06311227 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hairy cell leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-09-09 | NCT06311227 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
21 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.